share_log

Novartis AG | 6-K: Novartis Receives Fda Approval for Fabhalta® (Iptacopan)

SEC announcement ·  Dec 5, 2023 20:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more